Vault-13

EQT Fund Management S.a r.l.

LUXEMBOURG, N4 · CIK 1834239 · 13F filing filed 2026-08-13

Exempt reporting adviser since 2017 · other (specify)

As an employer

$862.6m reported value -15.5% vs Q1 2026
5positions
100.0%in top 10
0 new 2 added 0 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 WAYSTAR HLDG CORP COM WAY WAY 24,879,437 $510.8m59.21% 59.21% UnchangedShares held: Q3 2025 24.9m, Q4 2025 24.9m, Q1 2026 24.9m, Q2 2026 24.9m
2 PHARVARIS N V COM PHVS PHVS 3,424,609 $118.4m13.73% 13.73% UnchangedShares held: Q3 2025 3.4m, Q4 2025 3.4m, Q1 2026 3.4m, Q2 2026 3.4m
3 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 6,950,294 $96.4m11.18% 11.18% AddedShares held: Q3 2025 5.9m, Q4 2025 5.9m, Q1 2026 5.9m, Q2 2026 7.0m +1.1m +1,050,000 17.8%
4 EVOMMUNE INC COM SHS EVMN EVMN 5,288,313 $70.3m8.15% 8.15% AddedShares held: Q3 2025 0, Q4 2025 4.9m, Q1 2026 4.9m, Q2 2026 5.3m +358.7k +358,680 7.3%
5 AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB AGMB 5,141,992 $66.7m7.74% 7.74% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.1m, Q2 2026 5.1m